Zhifei Biological

China’s Vaccine Sector Surges: Hualun Vaccine Hits 20% Limit Up in Major Market Rally

China Finance Tech in ChinaBiotech, Bohui Innovation, CanSino, Gintic, Haili Bio-Pharmaceutical, Healthcare, Hualun Vaccine, Kangle Weishi, Pharmaceuticals, Zhifei Biological

January 26, 2026